OBJECTIVE: Electronic health records (EHRs) have the potential to improve completeness and timeliness of tuberculosis (TB) surveillance relative to traditional reporting, particularly for culture-negative disease. We report on the development and validation of a TB detection algorithm for EHR data followed by implementation in a live surveillance and reporting system. METHODS: We used structured electronic data from an ambulatory practice in eastern Massachusetts to develop a screening algorithm aimed at achieving 100% sensitivity for confirmed active TB with the highest possible positive predictive value (PPV) for physician-suspected disease. We validated the algorithm in 16 years of retrospective electronic data and then implemented it in a real-time EHR-based surveillance system. We assessed PPV and the completeness of case capture relative to conventional reporting in 18 months of prospective surveillance. RESULTS: The final algorithm required a prescription for pyrazinamide, an International Classification of Diseases, Ninth Revision (ICD-9) code for TB and prescriptions for two antituberculous medications, or an ICD-9 code for TB and an order for a TB diagnostic test. During validation, this algorithm had a PPV of 84% (95% confidence interval 78, 88) for physician-suspected disease. One-third of confirmed cases were culture-negative. All false-positives were instances of latent TB. In 18 months of prospective EHR-based surveillance with this algorithm, seven additional cases of physician-suspected active TB were detected, including two patients with culture-negative disease. A review of state health department records revealed no cases missed by the algorithm. CONCLUSIONS: Live, prospective TB surveillance using EHR data is feasible and promising.
OBJECTIVE: Electronic health records (EHRs) have the potential to improve completeness and timeliness of tuberculosis (TB) surveillance relative to traditional reporting, particularly for culture-negative disease. We report on the development and validation of a TB detection algorithm for EHR data followed by implementation in a live surveillance and reporting system. METHODS: We used structured electronic data from an ambulatory practice in eastern Massachusetts to develop a screening algorithm aimed at achieving 100% sensitivity for confirmed active TB with the highest possible positive predictive value (PPV) for physician-suspected disease. We validated the algorithm in 16 years of retrospective electronic data and then implemented it in a real-time EHR-based surveillance system. We assessed PPV and the completeness of case capture relative to conventional reporting in 18 months of prospective surveillance. RESULTS: The final algorithm required a prescription for pyrazinamide, an International Classification of Diseases, Ninth Revision (ICD-9) code for TB and prescriptions for two antituberculous medications, or an ICD-9 code for TB and an order for a TB diagnostic test. During validation, this algorithm had a PPV of 84% (95% confidence interval 78, 88) for physician-suspected disease. One-third of confirmed cases were culture-negative. All false-positives were instances of latent TB. In 18 months of prospective EHR-based surveillance with this algorithm, seven additional cases of physician-suspected active TB were detected, including two patients with culture-negative disease. A review of state health department records revealed no cases missed by the algorithm. CONCLUSIONS: Live, prospective TB surveillance using EHR data is feasible and promising.
Authors: Ross Lazarus; Michael Klompas; Francis X Campion; Scott J N McNabb; Xuanlin Hou; James Daniel; Gillian Haney; Alfred DeMaria; Leslie Lenert; Richard Platt Journal: J Am Med Inform Assoc Date: 2008-10-24 Impact factor: 4.497
Authors: Deborah S Yokoe; Steven W Coon; Rachel Dokholyan; Michael C Iannuzzi; Timothy F Jones; Sarah Meredith; Marisa Moore; Lynelle Phillips; Wayne Ray; Stephanie Schech; Deborah Shatin; Richard Platt Journal: Emerg Infect Dis Date: 2004-08 Impact factor: 6.883
Authors: Anil A Panackal; Nkuchia M M'ikanatha; Fu-Chiang Tsui; Joan McMahon; Michael M Wagner; Bruce W Dixon; Juan Zubieta; Maureen Phelan; Sara Mirza; Juliette Morgan; Daniel Jernigan; A William Pasculle; James T Rankin; Rana A Hajjeh; Lee H Harrison Journal: Emerg Infect Dis Date: 2002-07 Impact factor: 6.883
Authors: Michael Klompas; Jason McVetta; Ross Lazarus; Emma Eggleston; Gillian Haney; Benjamin A Kruskal; W Katherine Yih; Patricia Daly; Paul Oppedisano; Brianne Beagan; Michael Lee; Chaim Kirby; Dawn Heisey-Grove; Alfred DeMaria; Richard Platt Journal: Am J Public Health Date: 2012-06 Impact factor: 9.308
Authors: W Katherine Yih; Noelle M Cocoros; Molly Crockett; Michael Klompas; Benjamin A Kruskal; Martin Kulldorff; Ross Lazarus; Lawrence C Madoff; Monica J Morrison; Sandra Smole; Richard Platt Journal: Public Health Rep Date: 2014 Jan-Feb Impact factor: 2.792
Authors: Cason Schmit; Gregory Sunshine; Dawn Pepin; Tara Ramanathan; Akshara Menon; Matthew Penn Journal: Public Health Rep Date: 2017-08-16 Impact factor: 2.792
Authors: Wendy Blumenthal; Temitope O Alimi; Sandra F Jones; David E Jones; Joseph D Rogers; Vicki B Benard; Lisa C Richardson Journal: J Am Med Inform Assoc Date: 2020-07-01 Impact factor: 4.497
Authors: Laura Jean Podewils; Emily Alexy; Stephani Jean Driver; James E Cheek; Robert C Holman; Dana Haberling; Meghan Brett; Eugene McCray; John T Redd Journal: Public Health Rep Date: 2014 Jul-Aug Impact factor: 2.792
Authors: Michael Klompas; Michael Murphy; Julie Lankiewicz; Jason McVetta; Ross Lazarus; Emma Eggleston; Patricia Daly; Paul Oppedisano; Brianne Beagan; Chaim Kirby; Richard Platt Journal: Online J Public Health Inform Date: 2011-12-22